Keraplast News

Replicine Functional Keratin to have strong presence at SAWC spring 2012

Keraplast — Wed, 07 Mar 2012 20:36:56 +0000

Keraplast Technologies will showcase Replicine Functional Keratin advanced wound care technology at SAWC spring April 19-22 at the Georgia World Congress Center, Atlanta, Georgia.

Latest clinical research will be outlined in four poster presentations at the symposium:

Maximizing Healing Outcomes with Keratin Based Wound Products,

Rogue Valley Medical Center, Oregon, poster CS-08

A Pilot Study of Keratin Dressings in Skin Graft Donor Sites,

Christchurch Public Hospital, New Zealand, poster CS-25

A Case Study Series Using Keratin Based Technology for Skin Tears,

Total Care Health Services, New Zealand, poster CS-88

The Impact of Keratin Protein on Keratinocyte Cell Growth and the Implications for Keratin Based Wound Treatments,

The University of Miami Miller School of Medicine, poster LB-20

In addition, company representatives will be meeting wound care experts from across the US at booth 1111 in the exhibition hall.

To join the discussion and learn more about the new paradigm in wound healing please come visit us at booth 1111.

Keraplast Technologies Appoints Marathon Medical As Distributor To The VA. Keraplast Technologies Wound Care Line Now Available Within U.S. Government’s Healthcare System.

Keraplast — Wed, 23 Nov 2011 03:21:33 +0000

San Antonio, TX., November, 23, 2011 – Keraplast Technologies., the provider of Replicine Functional Keratin advanced wound care products, today announced it has signed a distribution agreement with Marathon Medical (Commerce City, CO) and applied to be added to Marathon Medical’s existing Federal Supply Schedule (FSS) contract, administered by the Department of Veterans Affairs (VA) on behalf of the U.S. General Services Administration (GSA).

The arrangement allows Keraplast Technologies to expand the availability of its advanced Replicine Functional Keratin advanced wound care products in partnership with Marathon Medical throughout the entire federal healthcare system, the largest healthcare provider in the United States with over 1,300 Veterans health facilities, Department of Defense medical treatment facilities, Military Hospitals, Indian Health Service Hospitals and other government agencies.

“We are very honored to have secured this contract, which not only offers a multitude of opportunities to give patients access to our life saving products, but ensures that veterans and active soldiers have access to our revolutionary technology” said Bill Moore, Chief Operating Officer. “Our partnership with Marathon Medical offers a breadth of coverage within the VA system, as they have both the necessary experience and expertise in government agency sales.”

Keraplast Technologies with it’s Keragel, Keramatrix, and Kerasorb product line is changing the approach to wound care with Bioactive Barrier support to patients. Its groundbreaking technology is introducing a new paradigm in management of acute and chronic wounds as well as burn patients, by accelerating the healing process.

“Marathon Medical with Keraplast Technologies affords us a great opportunity to benefit our ongoing commitment to honor all fellow U.S. military veterans and active military personnel,” said John St. Leger, president, Marathon Medical, a Service Disabled Veteran Owned Small Business and verified by the Center for Veterans Enterprise (CVE). “The Revolutionary products that Keraplast Technologies offers the VA and Department of Defense, facilitates a dramatically improved way of treating patients suffering from chronic wounds successfully, therefore avoiding more serious complications, or lengthy hospitalizations.”

Access to Replicine Functional Keratin advanced wound care technology is now well established across the US health care market. Keraplast CEO Michael Espensen added “Kerex LLC” is our DME supplier that gives public and private health providers direct access to Keraplast wound care technology, as well as private individuals in need of advanced wound care, such as families living with Epidermolysis Bullosa. Home health providers in the south west can access our technology through our partner Homesite Liveability. Adding Marathon Medical to our partners to give VA health facilities access to Replicine is a significant addition and builds on our solid foundation in the US wound care market.”

For more information contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it , visit www.keraplast.com or call 210 494 5596.

Keraplast Hair Rescue debuts at Cosmoprof

Keraplast — Tue, 13 Sep 2011 03:24:03 +0000

July 31st 2011. Keraplast Technologies launched the first of many innovative beauty products containing Replicine^TM Functional Keratin^® at the world’s premier beauty event, Cosmoprof North America 2011. The company’s ground breaking Hair Rescue product had salon professionals at the well-attended event boldly using the F-word as they sampled the product; “F” as in Functional Keratin.

With a unique keratin protein that is 91% identical to hair keratin, the new back bar treatment has the right amino acids in the right place to deliver genuine hair repair inside the fibre. Offering:

• 80% less breakage

• 97% improvement in shine

• 83% boost in color symmetry

• 78% more natural looking color

Simply put, Replicine^TM can do what other keratins cannot.

For more information on Hair Rescue with Replicine^TM Functional Keratin^® please contact:

Bill Moore

Chief Operating Officer

Keraplast Technologies, LLC

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Office: 210.494.5596

Fax: 210.490.6464

Mobile: 760.936.7932

Skype: WilliamDMoore11

www.keraplast.com

Keratin Advanced Wound Care Technology Engages Leading US Wound Experts

Keraplast — Mon, 12 Sep 2011 04:10:33 +0000

The introduction of a new paradigm in wound healing will continue at SAWC fall, Las Vegas October 13-15 2011.

Please come and visit Keraplast at booth 312 to learn more about Replicine^TM Functional Keratin^® advanced wound care technology and receive a complimentary DVD of the specialist Keratin Protein Advanced Wound Care symposium, held earlier this year.

The symposium entitled:

Keratin protein advanced wound care, a new paradigm in wound healing, held at SAWC, Dallas in April 2011, included specialist clinicians and scientific experts in the keratin field presenting the latest research and clinical findings on the emerging use of Replicine^TM Functional Keratin^® protein in wound care. An audience of wound care experts at the forefront of advanced care in the US heard the following series of talks:

Clinical Evaluation of Functional Keratin Wound Dressings

Robert S. Kirsner, MD, PhD, Professor, Vice Chairman & Stiefel Laboratories Chair, Department of Dermatology & Cutaneous Surgery, Chief of Dermatology University of Miami Miller School of Medicine

Keratin Formulations Promote Epithelialization in vitro and in vivo

Marjana Tomic-Canic, Ph.D, Research Professor, University of Miami Miller School of Medicine Department of Dermatology &Cutaneous Surgery

A Biodegradable Interface in Negative Pressure Wound Therapy

William Thompson, MD, Vascular surgeon, The Clinic of Mississippi, Jackson, Mississippi

Replicine^TM Functional Keratin^®Advanced Wound Dressings

Robert Kelly, Ph.D, Research Director, Keraplast Technologies, San Antonio, Texas.

Copies of the symposium are available on DVD. Please contact us to receive your copy, or visit us in Las Vegas October 13-15 at SAWC fall.

As a result of the interest in this new paradigm in wound healing, Keraplast Technologies is working closely with a pioneering group of wound care professionals, introducing keratin advanced wound care technology in clinics across the US.

Peter Coppola Haircare to Debut New Line on ShopNBC

Keraplast — Tue, 22 Mar 2011 00:37:10 +0000

Exclusive salon styling products from internationally known Peter Coppola Haircare to Launch March 25 on Premium Interactive Retailer

Boca Raton, FL – March 22, 2011 – Peter Coppola Haircare announced today the premiere of its world-recognized brand on ShopNBC, a premium interactive retailer via TV, Internet and mobile. Peter Coppola’s internationally recognized brand debuts a line of salon styling products that create smooth, silky, voluminous hair instantly by eliminating frizz, curls and wavy unmanageable hair. The two-day premiere will debut on ShopNBC Friday, March 25 at 11am, 5pm & 9pm ET and Saturday, March 26 at 2am ET.

Peter Coppola is an internationally recognized stylist with over 40 years of experience in the professional hairstyling business and salon and styling product industry. With over 30 salons worldwide, Peter has trained countless stylists and has been featured in numerous publications. He is revolutionizing the anti-aging hair care and straightening market with his innovative CopaGen Complex^TM hair care system.

Available exclusively on the ShopNBC network, Peter Coppola introduces the his CopaGen Complex^TM styling products, formulated with Keraplast Technologies, LLC (San Antonio, TX) Replicine™ brand Functional Keratin^®proteins. The advanced proprietary keratin proteins utilized within the CopaGen Complex^TM mimic the hair’s natural structure, enabling absorption of the proteins to rescue, restore and protect hair from the inside out. Peter’sline of styling products create instantly smooth and silky hair at-home, without the cost of going to a salon.

Peter Coppola Haircare Favorites Include:

Peter Coppola 4-Piece CopaGen Smoothing System (C53300)

Four-piece system includes pre-treatment, shampoo, conditioner and protein treatment. Designed to smooth hair in five minutes by elimating frizz, curl and wavy unmanageable hair. Formulated with no harsh chemicals or odor.

Peter Coppola Mudd Texture Balm (C53301)

Defines, shapes, and directs styling with a non-sticky, non-greasy feel. Ultra light formula adds texture to hair for more manageable styling.

Peter Coppola Myst Hairspray Duo (C53303)

Self-adjusting nozzle offers three levels of hold – light, medium and firm. Formulated to add fullness, texture and lift with lasting hold

“The Replicine™ brand Functional Keratin® technology is the best protein ingredient I have ever seen in a hair care line. The results are stunning. This is the best formulation I have ever created and gives salon results at home,” said Peter.

About Replicine™ brand Functional Keratin®.

Replicine™ Functional Keratin® protein is closer in form and function to human hair keratin than any other material previously produced. Reversal of hair damage can only be achieved with Replicine brand Functional Technology that contains all of the essential components of the native protein.

Replicine Functional Keratin™ presents the hair with the exact building blocks needed for repair, rescue, renewal and protection in a form suitable to be delivered from a wide range of familiar hair care formulations.

Rescue severely damaged hair through salon delivered treatments
Repair and restore hair strength and condition through daily wash and care formulations
Create more natural, even colors through pre-color keratin treatments
Control frizz and style through keratin treatments and straightening systems

For more information on Peter Coppola Haircare, please visit www.ShopNBC.com keyword: Peter Coppola.

Contacts

ShopNBC

Anthony Giombetti,

612-308-1190

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Keraplast Technologies, LLC

Bill Moore, COO

210-494-5596

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

www.keraplast.com/hair-care

Keratin protein advanced wound care symposium at SAWC April 14, 2011

Keraplast — Mon, 07 Mar 2011 01:36:09 +0000

Keraplast Technologies proudly presents a specialist symposium at SAWC, Dallas, TX, April 14, 2011. Senior clinicians, across a broad spectrum of wound care fields, will share their experiences using Functional Keratin devices, including:

Case study series of the treatment of venous leg ulcers;
Case study series demonstrating substantial benefit using keratin products in the treatment of acute and chronic wounds arising from Epidermolysis Bullosa;
Improvement of the wound-spacer interface when using keratin wound care products in combination with negative pressure wound therapy.

In addition to experiences in the clinic, the use of keratin to accelerate the healing of acute wounds in standardized porcine models will be presented as well as the fundamental science of utilizing keratin protein in a way that maintains structure and function.

Speakers presenting at the symposium include:

Robert S. Kirsner, MD, PhD

Professor, Vice Chairman & Stiefel Laboratories Chair, Department of Dermatology & Cutaneous Surgery, Chief of Dermatology University of Miami Miller School of Medicine

Stephen C. Davis, Ph.D

Research Professor, University of Miami Miller School of Medicine Department of Dermatology &Cutaneous Surgery

William Thompson, MD

Vascular surgeon, The Clinic of Mississippi, Jackson, Mississippi

Robert Allen Smith, MD

Clinical Director, Keraplast Technologies, Plastic Surgeon, The Clinic of Mississippi, Jackson, Mississippi

Robert Kelly, Ph.D

Research Director, Keraplast Technologies, San Antonio, Texas

Keraplast will also be exhibiting their range of Functional Keratin wound care products at booth 1111 of the SAWC exhibition, April 14-17 2011, Gaylord Texan Hotel and Convention centre, Dallas, TX. Come visit us to learn more about the new paradigm in wound healing.

Patent coverage for orthopedic devices and composite materials

Hairy — Thu, 30 Sep 2010 19:52:55 +0000

September 30th 2010, San Antonio TX, USA. Keraplast Technologies, a San Antonio based biotechnology company, announced today the issuing of two significant patents extending the global coverage of the company’s keratin protein technology. The Japanese patent office issued “orthopedic materials derived from keratin”, Japanese patent number 4,551,761. Dr. Robert Allen Smith, clinical director for the company described the milestone as very significant. “We established some time ago the improved healing outcomes that can be achieved using keratin based materials in medical devices. Regenerative medicine is a key area of future development and keratin protein is a cornerstone material for future regenerative medicine products. Improved bone healing is possible from the use of our keratin based technology, protected by this patent, illustrates the importance of keratin in the future of orthopedic surgery”. In a further development, the company announced the issuing of US patent 7,767,756, “composite materials containing keratin”. Paul Rohricht, Chief Operating Officer for the company described the importance of the patent “Currently, there is significant interest in biobased materials as in finding biobased alternatives to oil derived polymers. To achieve all of the properties we expect from oil derived polymers will require some modification to what the natural world has provided us with. This patent is an important part of the biobased materials future, demonstrating how our keratin technology can be manipulated with a range of different chemical entities.”

About Keraplast

Keraplast Technologies, LLC., is a U.S. commercial-stage biotechnology company headquartered in San Antonio, TX, with manufacturing and R&D operations in Christchurch, New Zealand. Established in 1996, Keraplast scientists have developed from safe, abundant natural sources, novel extraction processes which preserve the natural properties of keratin. Replicine™ brand keratin is a fully functional protein, and is used in a diverse range of products, from medical devices to hair and skin care products. The Keraplast Replicine technology is secured under an expanding portfolio of more than 180 U.S. and international patents.

Wound care patent coverage extended

Hairy — Fri, 30 Jul 2010 19:54:24 +0000

July 30th 2010, San Antonio TX, USA. Keraplast Technologies, a San Antonio based biotechnology company, announced today expansion of its patent estate in the area of wound care. Dr Robert Allen Smith, Clinical Director for the company commented “through extensive pre-clinical and clinical studies we have determined the substantial benefits possible from the use of our keratin based wound dressings, when managing chronic wounds, or in acute wound healing and also in the management of severe skin disorders such as epidermolysis bullosa. The commercial foundation for our range of wound care products is greatly helped by the issuing of this patent.” Michael Espensen, CEO, further commented “we own the most significant patent estate for keratin. Our wound care products are well protected by numerous issued US patents and this additional protection gives a greater level of confidence to us and our commercial partners in this area.”

About Keraplast

Keraplast sponsor DEBRA Epidermolysis Bullosa patient care conference

Hairy — Mon, 10 May 2010 19:57:00 +0000

May 10th 2010, San Antonio TX, USA. Keraplast Technologies, a San Antonio based biotechnology company, reported successful sponsorship and participation at the Dystrophic Epidermolysis Bullosa Research Association Patient Care conference in Cincinnati. Paul Rohricht, Chief Operating Officer for the company, described the involvement at the conference, “Keraplast has developed proprietary wound healing products, in particular the keratin rich gel Keragel, that have shown to offer significant quality of life improvements to families suffering from the severe skin disorder Epidermolysis Bullosa. We are proud to support the EB community and sponsor the patient care conference. At our stand we met many families and clinicians involved with EB and look forward to working more closely with them. Our products are approved by the FDA and will soon be available commercially for regular wound management and prevention.” Also at the conference Alan Arbuckle, Associate Professor of Paediatric and Dermatology and Director of the Epidermolysis Bullosa Centre of Excellence at the The Childrens Hospital, Denver, reported on recent advances in wound management for EB, and included discussion on his successful evaluation of Keragel T conducted in his clinic. “We are endeavouring to work closely with the clinical leaders in the field of EB, such as Professor Arbuckle, and it is very exciting to see good outcomes from evaluations that these health care professionals are conducting in their clinics” Paul Rohricht, said.

About Keraplast

Keraplast wound dressings presented at SAWC 2010

Hairy — Wed, 14 Apr 2010 19:57:37 +0000

April 2010, San Antonio TX, USA. Keraplast Technologies, a San Antonio based biotechnology company presented findings of a case study series of venous leg ulcers. Robert Kirsner, Professor, Vice Chairman & Stiefel Laboratories Chair Department of Dermatology & Cutaneous Surgery and Chief of Dermatology at the University of Miami Hospital and the University of Miami Miller School of Medicine, presented a poster detailing the performance of the three Functional Keratin wound dressings, Keragel, Keramatrix and Kerasorb, on hard to heal venous leg ulcers. Wounds defined as having a 13% healing rate, according to criteria developed at the University of Pittsburgh, were included in the study. When receiving keratin dressings 71% of this wound type healed representing a significant improvement in healing rate.